BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects

We aimed to investigate neutralizing antibody titers (NtAbT) to the P.1 and B.1 SARS-CoV-2 variants in a cohort of healthy health care workers (HCW), including 20 previously infected individuals tested at baseline (BL<sub>inf</sub>, after a median of 298 days from diagnosis) and 21 days...

Full description

Bibliographic Details
Main Authors: Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, Adele Boccuto, Daniela Zago, Monica Basso, Filippo Dragoni, Saverio Giuseppe Parisi, Maurizio Zazzi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Life
Subjects:
SARS-CoV-2 vaccination
neutralizing antibodies
live virus neutralization
B.1 variant
P.1 variant
previously infected and uninfected subjects
Online Access:https://www.mdpi.com/2075-1729/11/9/896

Internet

https://www.mdpi.com/2075-1729/11/9/896

Similar Items